Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results
- 1 November 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8) , 3229-3231
- https://doi.org/10.1016/s0041-1345(01)02373-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimusLiver Transplantation, 2001
- Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)Liver Transplantation, 2001
- Rapamycin in transplantation: A review of the evidenceKidney International, 2001
- Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicityClinical Transplantation, 2000
- Sirolimus-tacrolimus combination immunosuppressionThe Lancet, 2000
- SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1Transplantation, 1999
- What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression?Annals of Surgery, 1999
- SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATIONTransplantation, 1999
- CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATIONTransplantation, 1998